The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
Open accessAbstract
Fragile X syndrome (FXS) is caused by an expanded CGG repeat (> 200 repeats) in the 5' untranslated portion of the fragile mental retardation 1 gene (FMR1), leading to deficiency or absence of the FMR1 protein (FMRP). FMRP is an RNA carrier protein that controls the translation of several other genes that regulate synaptic development and plasticity. Autism occurs in approximately 30% of FXS cases, and pervasive developmental disorder, not otherwise specified (PDD-NOS) occurs in an additional 30% of cases. Premutation repeat expansions (55 to 200 CGG repeats) may also give rise to autism spectrum disorders (ASD), including both autism and PDD-NOS, through a different molecular mechanism that involves a direct toxic effect of the expanded CGG repeat FMR1 mRNA. RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS), in premutation carriers in late life. In studies of mice bearing premutation expansions, there is evidence of early postnatal neuronal cell toxicity, presenting as reduced cell longevity, decreased dendritic arborization and altered synaptic morphology. There is also evidence of mitochondrial dysfunction in premutation carriers. Many of the problems with cellular dysregulation in both premutation and full mutation neurons also parallel the cellular abnormalities that have been documented in autism without fragile X mutations. Research regarding dysregulation of neurotransmitter systems in FXS, including the metabotropic glutamate receptor (mGluR)1/5 pathway and γ aminobutyric acid (GABA)A pathways, have led to new targeted treatments for FXS. Preliminary evidence suggests that these new targeted treatments will also be beneficial in non-fragile X forms of autism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The majority of FXS patients have social anxiety and almost a third have symptoms that overlap with ASD (Hagerman et al., 2010).”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hagerman et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“This variable expressivity has parallels in known associations of ASD with Mendelian genes like FMR1 or TSC2, which are near fully penetrant for syndromic features of Fragile X or Tuberous Sclerosis, respectively, but only partially penetrant for ASD (Hagerman et al., 2010; Wiznitzer, 2004).”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Hagerman et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.006 · Cited by 2,882 · cited 1×
“Because FXS is the most common single gene cause of autism, responsible for 2% to 6% of all cases of autism, it is clinically recommended that all individuals diagnosed with autism or ASD should have the FX DNA test (both PCR and Southern blot) when the etiology of their autism is not known [1-4].”
BackgroundThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 2×
“Bear and colleagues have proposed the mGluR theory of FX, suggesting that the deficits associated with FXS are related to upregulation of the downstream effectors of the mGluR5 pathway, leading to enhanced long-term depression (LTD), and that treatment with an mGluR5 antagonist could be a targeted treatment for FXS [1…”
BackgroundγH2AX: a sensitive molecular marker of DNA damage and repair
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Leukemia · doi:10.1038/leu.2010.6 · Cited by 1,557 · cited 1×
“sions, and the fact that another DNA-repair protein, g-H2AX[96], is found in the intranuclear FXTAS inclu-”
BackgroundFragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051 · cited 1×
“FMRP is an mRNA-binding protein that is important for mRNA transport, mRNA stabilization and translation of mRNA into protein at the synapse [129-131].”
BackgroundAbnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046 · cited 1×
“Both FMRP and mGluRs play important roles in synaptogenesis and synaptic plasticity and in the absence of FMRP there are long, thin and immature dendritic spines in both human and animal models of FXS [137-142].”
BackgroundCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · cited 1×
“Support for the “mGluR theory” has been shown by generating FMR1 mutant mice with a 50% reduction in mGluR5 expression [145].”
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B., & Hagerman, P. J. (2001) · Neurology · doi:10.1212/wnl.57.1.127 · Cited by 964
Self-citationButler, M. G., Dasouki, M. J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takahashi, T. N., Miles, J. H., Wang, C. H., Stratton, R., Pilarski, R., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024646 · Cited by 778 · cited 1×
“Most of these proteins are associated with synapse formation and plasticity; however, the PTEN gene encodes a dual specificity phosphatase effecting G1 cell cycle arrest and/or apoptosis, and 17% (3/18) of individuals with autism and macrocephaly were found to have a PTEN mutation [51].”
BackgroundTassone, F., Hagerman, R. J., Taylor, A. K., Gane, L. W., Godfrey, T. E., & Hagerman, P. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302720 · Cited by 774 · cited 3×
“However, although carriers of premutation alleles have elevated FMR1 mRNA [27,80,81], the strongest argument for an RNA-based toxicity mechanism in both FXTAS and FXPOI [82-84], is that these clinical syndromes are limited to a premutation repeat range, where the gene is active; that is, low levels (or absence) of FMR…”
BackgroundSelf-citationFragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., Greco, C., Des Portes, V., Jardini, T., Levine, R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/374321 · Cited by 762 · cited 2×
“Subsequently, the late onset neurodegenerative disorder, FX-associated tremor ataxia syndrome (FXTAS), was described [19,20],”
BackgroundSelf-citation
Research works printed but not linked: 6
- Nishimura Y Martin CL Vazquez-Lopez A Spence SJ Alvarez-Retuerto AI Sigman M Steindler C Pellegrini S Schanen NC Warren ST Geschwind DH Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways Hum Mol Genet 2007 16 1682 1698 10.1093/hmg/ddm116 17519220 · DOI · Paper page
- Sellier C Hagerman P Willemsen R Charlet-Berguerand N DROSHA/DGCR8 sequestration by expanded CGG repeats leads to global micro-RNA processing alteration in FXTAS patients [abstract] 12th International Fragile X Conference; July 21-25; Detroit, MI 2010
- Aziz M Stathopulu E Callias M Taylor C Turk J Oostra B Willemsen R Patton M Clinical features of boys with fragile X premutations and intermediate alleles Am J Med Genet 2003 121B 119 127 10.1002/ajmg.b.20030 12898586 · DOI
- Farzin F Perry H Hessl D Loesch D Cohen J Bacalman S Gane L Tassone F Hagerman P Hagerman R Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation J Dev Behav Pediatr 2006 27 S137 144 10.1097/00004703-200604002-00012 16685180 · DOI · Paper page
- Miyashiro KY Beckel-Mitchener A Purk TP Becker KG Barret T Liu L Carbonetto S Weiler IJ Greenough WT Eberwine J RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice Neuron 2003 37 417 431 10.1016/S0896-6273(03)00034-5 12575950 · DOI · Paper page
- Kooy F Heulens I D'Hulst C Van der Aa N Bagni C Hassan B De Deyn P The GABAA receptor as a potential target for therapy of the fragile X syndrome [abstract] NFXF 12th International FX Conference; July 21 - 25; Detroit, MI 2010
Cited by
Autism spectrum disorder: neuropathology and animal models
Varghese, M., Keshav, N., Jacot-Descombes, S., Warda, T., Wicinski, B., Dickstein, D. L., Harony-Nicolas, H., De Rubeis, S., Drapeau, E., Buxbaum, J. D., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1736-4 · Cited by 536
Using Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“Sense (+, pin See also Table S5. which are near fully penetrant for syndromic features of Fragile X or Tuberous Sclerosis, respectively, but only partially penetrant for ASD (Hagerman et al., 2010; Wiznitzer, 2004).”
BackgroundThe dendritic tree and brain disorders
Kulkarni, V. A., & Firestein, B. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.03.005 · Cited by 390
Circuit level defects in the developing neocortex of fragile X mice
Gonçalves, J. T., Anstey, J. E., Golshani, P., & Portera-Cailliau, C. (2013) · Nature Neuroscience · doi:10.1038/nn.3415 · Cited by 279
Persico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 238
“Autism prevalence in FXS is approximately 30% and PDD-NOS ccurs in an additional 30% of cases [22].”
BackgroundInfluential
Metadata
- Authors
- Hagerman, R., Hoem, G., & Hagerman, P.
- Affiliations
- University of California Davis Medical Center (US)
- UiT The Arctic University of Norway (NO)
- University of California, Davis (US)
- Corresponding author
- Hagerman, Randi
- Venue
- Molecular Autism
- Published
- 2010
- Volume
- 1
- Issue
- 1
- Pages
- 12
- ISSN
- 2040-2392 (ISSN-L)
- PMC
- PMC2954865
- OpenAlex
- W2099899772
- Cited by
- 247
- References
- 175
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 7 · 2023: 4 · 2022: 12 · 2021: 19 · 2020: 5 · 2019: 12 · 2018: 8 · 2017: 14 · 2016: 22 · 2015: 16 · 2014: 33 · 2013: 32 · 2012: 28
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Autism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Norges Forskningsråd
- National Institute on Aging (RL1AG032115)
- National Institute of Dental and Craniofacial Research (UL1DE019583)
- National Center for Research Resources (HD02274, AG032115, AG032119, HD036071, 90DD05969, UL1RR024146, DE019583, DA024854)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD036071)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- fragile X syndrome, autism spectrum disorder, FMR1 gene, CGG repeat expansion, FMRP, fragile X premutation, fragile X-associated tremor/ataxia syndrome, RNA toxicity, synaptic development, mitochondrial dysfunction, GABAA receptor, targeted therapy, pervasive developmental disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. https://app.cochat.ai/papers/10.1186/2040-2392-1-12
- The paper
- Hagerman, R., Hoem, G., & Hagerman, P. (2010). Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Molecular Autism. https://doi.org/10.1186/2040-2392-1-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.